Waldencast plc continues to grow its presence in skincare and beauty through acquisitions like Obagi Medical, Milk Makeup, and Novaestiq Corp, leveraging strategic collaborations and product innovation. However, its financial performance has deteriorated sharply with soaring goodwill impairment charges and escalating losses that more than quadrupled year-over-year. Internal control deficiencies compound risks amid high debt costs and constrained liquidity. Future growth hinges on integrating acquisitions effectively while stabilizing operations and addressing governance weaknesses.